Global Antimicrobial Resistance Research and Development Hub | 13 Sep 2019

Recently, India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member.

  • Working with AMR(R&D) Hub would help India to expand existing capabilities, resources and collectively focus on new R&D intervention to address drug-resistant infections present in the country.
  • Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub is a collaboration of 16 countries, the European Commission, two philanthropic foundations and four international organizations (as observers).
  • It was launched in 2018 during the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017.
  • It is supported through a Secretariat, established in Berlin, Germany.
  • It aims to further improve the coordination of international efforts and initiatives to tackle Antimicrobial Resistance while further increasing investments into R&D for AMR.
  • The work of the Global AMR R&D Hub will be aligned to the priorities set by
  • It enforces the One Health Approach by including environmental aspects and veterinary medicine against antimicrobial resistance.
  • It integrates human and animal health, worldwide food safety and environmental factors.

Source: PIB